tert-Butyl(4R,6R)-2[[[6-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrolyl]ethyl]2,2-di-methyl-1,3-dioxan-4-yl]acetate 125971-95-1 98%
Price | Get Latest Price | |||
Packge | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-22
Product Details
- Product Nametert-Butyl(4R,6R)-2[[[6-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrolyl]ethyl]2,2-di-methyl-1,3-dioxan-4-yl]acetate
- CAS No.125971-95-1
- EINECS No.700-258-0
- MFC40H47FN2O5
- MW654.81
- AppearanceSolidWhite
- Melting point 144-148 °C(lit.)
- storage temp. Refrigerator
- Boiling point 678.0±55.0 °C(Predicted)
- density 1.14±0.1 g/cm3(Predicted)
Company Profile Introduction
We are a pharmaceutical company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. We have evolved our business and have, over the years, extended from manufacturing APIs and Intermediates to add CRAMS to our offerings, which has significant potential for the growth of our business.
Ajit Kamath, aged 51 years, is the Executive Chairman and Managing Director of our Company and was first appointed as an Additional Director in our Company on January 1, 2001. He holds a Bachelors Degree in Commerce from the University of Mumbai and has around 19 years of experience in the pharmaceutical industry. Prior to joining our Company he has worked with CEAT Financial Services Limited and was one of the promoters of Arch Commerz Private Limited, which reverse-merged into our Company pursuant to the Scheme of Rehabilitation. He has been instrumental in the acquisitions made by our Company since our acquisition of the Gurgaon Unit in December 2004. He has been involved and instrumental in planning and formulating the overall business strategy and developing business relations for our Company.
Supplier other products
Recommended supplier
-
VIP1年
- LOBERAN PHARMA
- tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate 125971-95-1 > 99.0
- Inquiry
- 2024-11-14
-
VIP1年
- Medec Dragon Private Limited
- tert-Butyl(4R,6R)-2[[[6-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrolyl]ethyl]2,2-di-methyl-1,3-dioxan-4-yl]acetate 99%
- Inquiry
- 2024-03-19
-
VIP1年
- Trimax bio sciences private ltd
- 125971-95-1 98%
- Inquiry
- 2024-03-11
-
VIP1年
- Apicore Pharmaceuticals Pvt Ltd
- 125971-95-1 tert-Butyl(4R,6R)-2[[[6-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrolyl]ethyl]2,2-di-methyl-1,3-dioxan-4-yl]acetate 98%
- Inquiry
- 2024-03-07
-
VIP1年
- Lavybens Pharma
- tert-Butyl(4R,6R)-2[[[6-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrolyl]ethyl]2,2-di-methyl-1,3-dioxan-4-yl]acetate 125971-95-1 98%
- Inquiry
- 2024-02-15
-
VIP1年
- Cubane Pharmaceuticals LLP
- 125971-95-1 99%
- Inquiry
- 2024-02-08
-
VIP1年
- Dr. ASCRO Bio Sciences Private Limited
- 125971-95-1 tert-Butyl(4R,6R)-2[[[6-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrolyl]ethyl]2,2-di-methyl-1,3-dioxan-4-yl]acetate 98%
- Inquiry
- 2024-01-24
-
VIP1年
- Gensynth Laboratories Pvt. Ltd
- tert-Butyl(4R,6R)-2[[[6-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrolyl]ethyl]2,2-di-methyl-1,3-dioxan-4-yl]acetate 98%
- Inquiry
- 2024-01-22
-
VIP1年
- Varanous Labs Pvt Ltd
- Atorvastatin Impurity I 125971-95-1 98%
- Inquiry
- 2023-12-26
- Since:2020-01-01
- Address: Titanic Building, 3rd Floor, Tex Centre, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Maha